Penn Medicine Physician Interviews: Recent Episodes
Penn Medicine
Penn Medicine Physician Interviews podcast highlights conversations with Penn physicians as they share recent advances in the field of medicine, clinical research updates, new medical technology and best practices in patient care.
Gynecologist oncologist Nawar Latif, MD, MPH, MSCE, offers a brief introduction to the 3rd Gynecologic Oncology Advanced Surgical Course at Penn Medicine for fellows in-training and practicing gynecologic oncologists. Dr. Latif discusses the benefits of cadaver dissection and individualized post-course preceptorship as precedents to the mastery of advanced radical pelvic and high yield gynecologic oncology procedures.
Head and neck reconstructive surgeon Karthik Rajasekaran, MD, and radiation oncologist Michelle Gentile, MD, review recent clinical investigations of intensity-modulated radiation therapy and proton therapy for deintensification of HPV+ head and neck cancers, and discuss the advantages of head and neck cancer therapy at Penn Medicine. (Part 2 of 2)
Leukemia specialist Matthew Connor addresses parsing the genomic determinants of the leukemias for diagnosis, and reviews the mystery of mixed phenotype acute leukemia, a rare type of acute leukemia that expresses phenotypic markers of both AML and ALL.
Learn more about Matthew Connor, MD
Head and neck reconstructive surgeon Karthik Rajasekaran, MD, and radiation oncologist Michelle Gentile, MD, discuss the nuances and benefits of deintensification, a personalized approach to care for individuals with HPV-positive head and neck cancers that aims to maintain high cure rates while reducing long-term toxicities. (Part 1 of 2)
Dr. John Plastaras offers the insight of a clinician researcher to an engaging discussion of the emergence and application of low-dose radiation therapy as a non-invasive, non-pharmacologic alternative for chronic and refractory osteoarthritis in individuals seeking relief from chronic joint pain when other treatments fail.
Learn more about Logan Barnes, PA-C
Learn more about John Plastaras, MD, PhD
Neurosurgeon Christina Jackson, MD, and radiation-oncologist Emily Lebow, MD, discuss the treatment of meningiomas, tumors of the meninges renowned for their tendency to recur following resection, and
review the tools used to image (DOTATATE-PET), target (Lutathera), and destroy (GammaTile) residual meningioma cells to prevent recurrence of the disease.
Neurosurgeon Christina Jackson, MD, and radiation-oncologist Emily Lebow, MD, offer their unique perspectives on recent advances in the surgical and radiotherapeutic management of meningioma, complicated, often recurrent tumors that rise in the meninges of the brain and spinal cord.
Learn more about Emily Lebow, MD
Clinician-researcher Ravi K. Amaravadi, MD, recalls a time within recent memory when no therapies existed for Stage IV metastatic melanoma, and reflects upon the 17 FDA-approved therapies now available to treat the disease. In this podcast, Dr. Amaravadi notes that many of these agents— including molecularly targeted therapy, immunotherapy in solid tumors, TIL cellular therapy, and personalized mRNA cancer vaccines—were pioneered at Penn Medicine.
Learn more about Ravi K. Amaravadi, MD
Penn radiation oncologist Alexander Lin, MD, reviews the groundbreaking clinical study that established the equivalency of proton therapy to photon radiation (IMRT) as an adjunct for patients with HPV+ oropharyngeal cancer—finding in so doing that proton therapy can be used for deintensification of radiation treatment in this population. The study determined that proton therapy matched photon therapy in controlling cancer, and did so with fewer long-term side effects and better long-term outcomes, including survival.
Learn more about Alexander Lin, MD
Dr. Kimberly Stevenson offers an orthopaedic surgeon’s perspective on the muscle-sparing direct anterior approach (DAA) to total hip arthroscopy. DAA may bring about a faster recovery than the classic posterior and lateral approaches and has the potential for a lower risk of dislocation.
Learn more about Kimberly Stevenson, MD
Hematologist-oncologist Colin Thomas, MD, and dermopathologist Jina Chung, MD, review the diagnosis and treatment of the T cell lymphomas, including the nodal and extra nodal (cutaneous) variants, describe the journey from diagnosis to treatment for T cell lymphoma patients, clinical research ongoing and the coordinated effort at Penn Medicine and the Abramson Cancer Center to control these rare, complex, and resilient malignancies.
Learn more about Colin Thomas, MD
Learn more about Jina Chung, MD
In an illuminating discussion, gynecologic oncologist Noah Goldman, MD, discusses the comprehensive scope of his practice at Penn Medicine Princeton Health, including the types of cancers he treats, and expands upon the known benefit of the HPV vaccine, the mysteries of screening for endometrial and ovarian cancers, and the promise of being attentive to one’s own body when things seem awry.
Learn more about Noah Goldman, MD, MBA
Drs Sunil Singhal, Janos Tanyi, and James Delikatny discuss the 10 year anniversary of the Penn Center for Precision Surgery. A collaborative effort, the Center has the goal of advancing the practice and invention of intraoperative molecular imaging modalities. Together, the panel review the development and application of fluorescent contrast agents in surgery, relevant FDA-approvals originating at Penn (ie., Cytalux®), and the future of intraoperative imaging.
Drs Nadia Dawn Ali and Scott Peslak examine the pathology of sickle cell disease, its variable effects, and recent advances in treatment, including stem cell therapies and other new FDA-approved regimens for the disease.
Melanie Freas, DNP, CRNP, and cardiac surgery MSN, CRNP Katelyn Rosemann offer a comprehensive overview of the management of acute and chronic types A & B aortic dissection, with a consideration of long-term follow-up, the current status of genetic testing for aortic dissection risk, and the psychological effects of dissection survivorship.
Learn more about Melanie Freas, DNP, CRNP
Learn more about Katelyn Rosemann, MSN, CRNP
Dr. Melina Marmarelis offers an overview of biomarker testing—and particularly liquid biopsy—as a fulcrum of precision medicine at Penn Medicine in the determination of tailored treatments for patients with metastatic non-small cell lung cancer.
Surgeons Christina Jackson, César Briceño, and Jennifer Douglas of Penn Neurosurgery, Oculoplastics, and ENT discuss their combined roles in the transorbital approach (TOA) to tumors of the skull base. The TOA reaches meningiomas and other deep-seated tumors through the orbit of the eye to avoid craniotomy and its after-effects.
Penn Orthopaedics surgeon Charles Nelson, MD, reflects on his role as recently elected President of the American Board of Orthopaedic Surgery, as well as the organization’s history, its role in the development of orthopaedic surgeons, and the looming challenges of AI.
Learn more about Charles L. Nelson, MD
Abdominal wall hernias appear at points of congenital or acquired weakness in the abdominal muscle wall, and their correction involves an understanding of both the nature of the precipitating flaw and the character of the abdominal wall. In this podcast, Lancaster-based surgeon Kelly Janke, DO, discusses these elements in the context of advanced hernia surgery. and reviews the factors that predispose individuals to either good or less-than-optimal outcomes following intervention.
Lisa Dobruskin., MD, reviews the management of obesity at Penn Princeton Bariatrics with a focus on continuity of patient-oriented care and the pathophysiology of weight gain and loss. Dr. Dobruskin reviews current minimally invasive surgical offerings, offers guidance on weight-loss medications, and discusses the timing of intervention and other concerns for those considering bariatric surgery.
For more than two decades, advanced practice providers at the Penn Surveillance Clinic have monitored and counseled patients with bicuspid aortic valve (BAV) disease. A congenital disorder, BAV is associated with the connective tissue syndromes and in these and other affected populations is a leading cause of irreversible aortic root dilation, aneurysm, rupture, and dissection. Affiliated with the Center for Bicuspid Aortic Valve Diseases at Penn Medicine, the APP-led Surveillance Clinic follows patients as they progress from dilation to aneurysm to monitor the size of their aortic diameter via imaging, adjust treatment plans, and, when needed, prepare patients for surgery and recovery.
Obstetrician-gynecologist Dr. Sarita Sonalkar provides an insightful review of the Penn Pregnancy Early Access Center, or PEACE Program, an integrated family planning and urgent pregnancy care center. In her engaging discussion, Dr. Sonalkar highlights the various benefits and services of the Program, including shared decision-making, timely appointments, contraception, counseling, ultrasound and surgical services, and much more.
Aortic aneurysms contribute to thousands of aortic dissections and ruptures every year in the United States, and are virtually undetectable in the general population. In this podcast, cardiac surgeon Jeremy McGarvey, MD, describes the effort to detect aortic aneurysms and their multidisciplinary management at PennMedicine.
Learn more about Jeremy McGarvey, MD
Drs Timothy Markman and Keith Cengel review the devices, medications and surgical approaches to ventricular tachycardia (VT), an arrhythmia linked to sudden death, our current understanding of the origins of VT, and clinical research into new approaches at Penn, including RADIATE VT, which compares radioablation to radiofrequency for VT ablation.
Is there a surgical answer to intractable hypertension? Drs. Taisei Kobayashi and Debra Cohen offer their clinical insights (surgery and nephrology, respectively) on catheter-based renal denervation and its indications for patients with refractory hypertension, as well as supporting evidence for efficacy and precautions for eligibility.
The second most common hematologic malignancy, multiple myeloma has an incidence of ~35,000 new cases a year in the United States. In this episode, Drs. Adam Cohen and Shivani Kapur convene to lay out a roadmap for the treatment journey for patients with the disease, from early treatment options, particularly autologous transplant, to recent advances in immunotherapy, combination maintenance therapies, and clinical trials.
Dr. Leonid Emerel reviews the management of non-small cell and small cell lung cancer at the multidisciplinary cancer clinic in the Medical Arts Pavilion at Penn Medicine Princeton Thoracic Surgery. Dr Emeril reviews diagnostics, chemotherapy, immunotherapy and surgery, and the value of rapid access to the surgeons on staff.
Alexander W. R. Bridges, MD, offers the insight of a cardiothoracic surgeon to an engaging discussion of atrial fibrillation, its causes, risk factors, pathophysiology, populations affected, and treatments. The object of therapy, Dr. Bridges attests, is to stabilize the heart rhythm and reduce the lifetime risk of stroke and heart failure. Dr Bridges reviews the Cox-Maze 3 procedure, left atrial appendage removal, percutaneous ablation, and other advances for atrial fibrillation at Penn Medicine Lancaster General Health.
Heritability has long been known to play a role in aortic aneurysm and dissection for individuals with the Marfan and Loeys-Dietz syndromes. Recent research at Penn Medicine and elsewhere has revealed the presence of genetic variants linked to these syndromes in non-syndromic disease. In this podcast, clinical genetics specialist Staci Kallish, DO, discusses this phenomenon, reviews ongoing studies to determine the risk for aortic aneurysm and dissection in the general population, and the protocols for candidates for genetic evaluation and testing in at- risk populations.
Electrocardiologist Matthew A. Bernabei, MD, examines the history of ablation for atrial fibrillation and its latest iteration, pulsed field ablation, or PFA. Now available at Penn Medicine, PFA uses an electrical field rather than radiofrequency or cryotherapy to treat the aberrant signals that are the source of Afib. Unlike other ablation modalities, PFA is cardio-selective, and thus poses little risk to structures near the heart, including the esophagus.
Refer a patient:
Call our 24/7 provider-only line at (877) 937-7366
Submit via our secure online referral form
Cancer and surgery specialists Drs. Kara Maxwell, Daniel Lee, Jennifer Zhang, and Bryson Katona delve into the nuances of BRCA-positive breast, prostate, and pancreatic cancers in men. This wide-ranging discussion encompasses BRCA heritability, diagnostics, screening, risks, and treatment options.
Dr. Jonathan Nahas offers a concise overview of alcohol-related liver diseases, addressing their causes, consequences, and effects on the liver, and examines the importance of thorough assessment and management strategies, including liver transplantation.
Kendall Lawrence, MD, a specialist in aorta surgery, examines the physiology, symptomatology, types, and causes of acute aortic dissection and describes the management of these events at the Penn Aorta Center—including Center’s direct-to-OR program for patients presenting with acute aortic emergencies.
Dr. Nawar Latif offers a nuanced overview of heated intraperitoneal chemotherapy, or HIPEC, as an adjunct to surgery in women with ovarian cancer. The introduction of heated chemotherapy at the peritoneum greatly increases its absorption and minimizes the toxicity of therapy.
Dr. E. John Wherry, Director of the Colton Center for Autoimmunity at Penn Medicine, offers his insight on the Center’s therapeutic and novel research missions to revolutionize awareness, diagnosis and treatment of autoimmune diseases through collaborative, transformative, and translational science.
Penn radiation oncologist Karishima Khullar, MD, offers an overview of low-dose radiation therapy for patients who have not responded to medications, steroid injections, and other standard treatments for osteoarthritis.
Clinician-researcher Daniel Lefler, MD, reviews Afami-cel, the first FDA-approved immunotherapy designed to treat synovial cancer, a rare, aggressive soft-tissue malignancy.
Rare, heritable Li-Fraumeni Syndrome, imposes an approximate 90% risk of breast cancer and the sarcomas, among other cancers, over the lifetime of affected individuals. Drs. Suzanne MacFarland, and Kara Maxwell, discuss the urgent need for early diagnosis and intensive life-long monitoring, family dynamics, communication, advocacy and the avenues for care in Li-Fraumeni.
Dr. Anuja Dokras reviews the Women's Health Center for Clinical Innovation, a leader in clinical advances, research, and interactive programs for women throughout the reproductive cycle, from inspiring fertility (Fast Track to Fertility) to postpartum care (HeartSafe Motherhood) and beyond.
Dr. Elizabeth Anne Genovese offers an overview of peripheral artery disease, or PAD and its end-stage form, chronic limb-threatening ischemia, and discusses the treatments available at the Penn Advanced Limb Preservation (PALP) program, including investigational therapies for the “no-option” patient.
In this episode, Dr. Lisa Levine leads a discussion focusing on what burden does pregnancy place on the heart, and why some women and birthing people develop heart disease for the first time during pregnancy.
Rebecca Hamm, MD, provides an engaging overview of standardization and implementation science at Penn Medicine, a new field that seeks to inform health care change, particularly with regard to disparities in maternal outcomes and women’s health.
Dr. Stephen Bagley provides an overview of two enrolling clinical trials at Penn Medicine. The first explores targeted CAR T therapy in recurrent IDH wild-type glioblastoma; the second pairs two investigational drugs in the treatment-of recurrent IDH-mutant glioma.
Drs. Neilanjan Nandi and Anish Sheth of Penn Gastroenterology discuss the current set of colonoscopy and elucidate the advantages of GI Genius, a program that incorporates AI into practice to improve upon colonoscopy outcomes.
Fertility specialist Christine Skiadas, MD, offers her insight on the causes of the worldwide decline in male fertility, and how Penn Penn Fertility Care is approaching this mystery through genetic testing and assisted reproductive technologies, including in vitro fertilization.
Dr. Michael Ibrahim offers an overview of the history and application of the Ross procedure, a method of aortic valve replacement that offers an alternative to the complexities of mechanical and bioprosthetic valves for younger adults.
Drs. Christian Bermudez and Asad Ali Usman furnish a comprehensive overview of extracorporeal membrane oxygenation (ECMO) Program at Penn Medicine and its affiliates, which now averages 200 to 250 cases of ECMO support every year, and reflect on recent advances in technique, the novel introduction of ECMO for COVID-associated ARDS, and patient survival on ECMO for up to six months as bridge to transplantation.
Lorraine Boakye, MD, discusses the application and research behind wearable motion sensing accelerometers that measure changes in velocity throughout the day for patients recovering from Achilles tendon injuries.
Parsing a topic of great concern in the wake of acute brain injury, David Fischer, MD, reviews the RECOVER Program for Disorders of Consciousness at Penn Medicine. RECOVER (REcovery of COnsciousness Via Evidence-based medicine and Research) is an effort to establish a clinical infrastructure for decisions involving neuroprognostication, and to provide comprehensive, specialized, and longitudinal care to patients with disorders of consciousness resulting from acute brain injury.
In this episode, Drs. Charles Vollmer and Nuzhat Ahmad lead a discussion focusing on pancreatitis, and how the Penn Pancreatic Center of Excellence specializes in treatment.
In this episode, Drs. Samir Mehta and Derek Donegan review a new approach to pelvic fragility fracture repair at Penn Trauma and Fracture Services—a fixation device that curves to accommodate the unique structure of the pelvis.
In this episode Dr. Lawrence discusses TAVR vs. SAVR. Who is a candidate for TAVR or SAVR? Who is a candidate for TAVR or SAVR and what makes one the best choice for your patient.
The first installment of the podcast series from the specialists at Penn Medicine. This podcast will feature Dr. Scott Kasner, Vice-Chair for Clinical Affairs in Neurology at Penn Medicine. He will highlight the SELECT2 thrombectomy study.
In this episode, neurosurgeons Neil Malhotra, MD,. and James Schuster, MD, PhD, discuss the nuances and intricacies of spinal cancer, and the innovations, early diagnosis, research, and expertise in surgery, radiology, and medicine that motivate spinal oncology care at the Penn Spine Center.
In this episode, Host Melanie Cole joins Dr. Samir Mehta, Chief of the division of Orthopaedic Trauma and Fracture Care at Penn Medicine to review the treatment of clavicle fractures.
In this episode, we're highlighting commonly missed orthopedic trauma injuries with Dr. Samir Mehta.
In this episode, Dr. Christina Jackson leads a discussion focusing on highlighting endonasal approaches to skull-based surgery.
In this episode, Dr. Lorraine Boakye leads a discussion focusing on Achilles rupture and tendinopathy.
Host Melanie Cole, MS is joined by John M. Vasudevan, MD, CAQSM to discuss the Running Program and Endurance Sports Programs at Penn Medicine.
In this episode, Dr. Scott Kasner leads a discussion on SELECT2 Thrombectomy Study, and Penn's role in this study.
In this episode, Dr. Ty B. Dunn and transplant manager K. Louise Berry lead an interactive discussion highlighting total pancreatectomy islet auto
transplant.
Dr. James Metz, MD walks through some recent advancements, achievements, and milestones in the Radiation Oncology department at Penn Medicine.
In this episode, Dr. David Tarity leads a discussion focusing on the utilization of robotics in joint replacement surgery.
Giorgos Karakousis MD highlights retroperitoneal sarcoma. He shares the symptoms patients typically present with, the diagnostic criteria and treatment options for patients with retroperitoneal sarcoma. Additionally he shares what makes the Penn Medicine Abramson Cancer Center unique when it comes to diagnosing and treating retroperitoneal sarcoma and when it is important for physicians to refer their patients to Penn Medicine.
The combination of a growing number of patients with end-stage renal disease and a shortage of organs poses a significant challenge to the transplant community. Donor shortage is associated with unfavorable consequences: prolonged waiting time, and compromised graft and patient survival. Efforts are required to expand the donor pool and get more patients to transplant, and sooner. Amanda Leonberg-Yoo MD and Robert Redfield III MD, FACS offer a roadmap of innovation in living donor kidney transplantation at Penn Medicine.
Dimitriy Petrov MD discusses the modern care approach to spine surgery. He highlights how the field of neurosurgery in spinal care has evolved dramatically in recent years, the latest technical advances in neurosurgery for spinal trauma and complex care at Penn Medicine and what distinguishes these technologies from the current standard of care in the region.
Lee Hartner MD discusses what factors community physicians should take into account when deciding which lumps and bumps to biopsy. He highlights some of the challenges that physicians and patients experience when certain lumps and bumps have been biopsied or removed before these patients are seen by the team and he shares how the expertise of Penn Medicine pathologists contributes to the best outcomes for sarcoma patients.
Peter Abt MD and Kim Olthoff MD discuss responsible expansion of liver transplantation. They offer the benefits of the Penn Liver Transplantation program and what they see as the single greatest challenge facing the field of liver transplantation today. Additionally, they share how Penn is finding innovative ways to increase access to deceased donor liver transplantation and the recommendations for timing of referral in liver transplantation
Bobby Ndu MD, MBA highlights minimally invasive foot and ankle surgery. He shares how minimally invasive surgery differs from traditional foot and ankle surgery, the benefits of these procedures and what makes Penn Orthopaedics unique when it comes to minimally invasive foot and ankle surgery.
Bill Jaffe MD and Jennifer Lloyd-Harris MD, MPH discuss aquablation and BPH treatment. They share how many of the existing treatments for BPH involve a tradeoff between efficacy and complications, who it is indicated for and what procedural or operative advantages Aquablation brings to BPH therapy. Additionally, they offer how this new treatment complements the total approach to BPH at Penn Urology.
While pregnancy is safe to undertake, there are specific risks for women with MS trying to conceive. Rachel Brandstadter, MD discusses these concerns and how can they be addressed for women with MS.
Additionally, she explains the services Penn Medicine offers along the way, strategies for management of MS in the postpartum period and what referring providers should be aware of before they refer a patient to the MS and women’s health specialists at Penn Medicine.
While the incidence of heart failure with reduced ejection fraction (HFrEF) has decreased, the incidence of heart failure with preserved ejection fraction (HFpEF) continues to rise.
Stuart Prenner MD explains the role of ejection fraction in heart failure diagnostics and the clinical indicators referring providers should be aware of when considering HFpEF. He explores the diagnostic strategies the team at Penn Medicine employ and the specific interventions recently approved, including SGLT2 inhibitors. Lastly, he shares how the HFpEF program at Penn Medicine has the ability to care for these patients with a multidisciplinary team.
Ty Dunn MD, MS discusses simultaneous pancreas-kidney (SPK) transplant. She emphasizes the relationship between type 1 diabetes and the destruction of these organs as well as the indications for both pancreas transplantation alone and SPK transplant. She shares the differences in the outcomes for SPK transplant versus pancreas-alone, or pancreas after kidney transplant and she tells us about the new allocation policies for kidney and pancreas transplantation. Lastly, she offers the recommendations for timing of referral for SPK transplant evaluation, and the advantages for individuals considering Penn Medicine’s Kidney and Pancreas Transplant program.
Donald O'Rourke MD discusses investigating novel treatments for Glioblastoma Multiforme. He tells us more about this work, how it started, and how it’s going right now. He speaks about a cutting-edge trial waiting to open using CAR T cells for recurrent GBM, describes the difference from previous trials and how the Translational Center of Excellence at Penn Medicine really helped bring this novel treatment to fruition.
Nicole Saur, MD, discusses the launch of the PeRioperative Evaluation and Planning (PREP) Program at Penn Medicine and the PREP Program's multidisciplinary, multiphase approach for optimization of older patients undergoing colorectal surgery.
Noam Cohen, MD, PhD, discusses the role of taste receptors in the nose, the disease implications of these taste receptors, and his team's research on modulating taste receptors to treat chronic rhinosinusitis.
Noam Cohen MD, PhD discusses taste receptors. He shares whether the function of taste receptors in the nose have disease implications and can taste receptors be used as targets for therapy. He provides insight into some of the research he and his team are conducting around modulating taste receptors in order to treat chronic rhinosinusitis and he tells us about the innovations that his team’s research findings have led to, specifically, in the nasal irrigation system
Neil Taunk, MD, MSCTS, discusses Penn Medicine's high-dose rate brachytherapy, a new offering from Penn Medicine.
Neil Taunk MD, MSCTS discusses brachytherapy for prostate cancer. He shares the many types of brachytherapy available and the ideal candidate for this therapy. He also speaks about the importance of multidisciplinary care for better outcomes for these patients.
Joshua Levine, MD, discusses the internationally recognized Penn Neurocritical Care Program, the multidisciplinary treatment team and the advanced technology that is individualizing patient care at Penn Medicine.
Julia Glaser, MD, discusses the role of vascular surgery in critical limb ischemia treatment — the mission of the Penn Advanced Limb Preservation (PALP) Program, the population treated for critical limb ischemia, and how the PALP program utilizes multidisciplinary teams.
Cara Cipriano MD, MSc speaks about her position as the only female joint replacement surgeon at Penn Medicine.
Cara A. Cipriano, MD, MSc, Chief of Orthopaedic Oncology and Associate Professor of Orthopaedic Surgery, discusses her role at Penn Medicine and her commitment to diversify the field of orthopaedics.
Roger Cohen, MD, and Donald Siegel, MD, PhD, discuss the enrolling novel CAR T-Cell medullary thyroid cancer clinical trial at Penn Medicine, and which patients should participate in the clinical trial.
In this engaging interview, Rhondalyn McLean, MD, reviews the evolution of heart transplantation in the U.S. and at Penn Medicine, including indications, the importance of early referral, and long-term survival. She also examines recent transplant allocation changes and how Penn Medicine is working to expand the donor pool, including transplanting hearts from individuals with hepatitis C.
L. Scott Levin MD, FACS, FAOA discusses new lower extremity salvage guidelines and The Penn Medicine Orthoplastic Limb Salvage Center. He shares the new guidelines, what research has taken place to initiate the changes and how this will affect practices at the Penn Orthoplastic Limb Salvage Center.
Doraid Jarrar MD, FACS, FCCP discusses the new guidelines for LDCT Scans announced by the USPSTF and what led to the expansion of the screening criteria.
Maria Crespo MD discusses the new consensus statement on lung transplant for connective tissue disorders. This new international consensus statement highlights the importance of consistency in patient selection, surgical and multi-disciplinary post-transplant management.
Chris Anthony, MD shares how hip labral tears are being addressed by the Penn Hip Preservation program and the importance of early referral for hip preservation evaluation and treatment.
Nithin Adappa, MD and John V Bosso, MD discuss Penn Medicine's AERD Center. They share how the treatment for AERD has evolved, the treatment protocol at Penn Medicine, including surgical and medical management and what a physician should do if they have a patient with suspected AERD.
Linda Ronis-Kass Au.D and Natalie Watts Au.D explore the field of audiology. They share the types of conductive hearing losses that can be surgically corrected or improved and the latest treatments and newer implantable hearing devices.
Colleen Gaughan MD discusses cardiothoracic surgery and The Harron Lung Center at Penn Medicine. She shares the fact that only 5% of cardiothoracic surgeons are female. In this podcast, please meet Dr. Colleen Gaughan: Female Thoracic Surgeon
Gwo-Chin Lee MD discusses robotic knee surgery. He shares how Penn has designed its new robotic joint replacement program and why Penn has decided now is the right time to add this option to its array of surgeries. He describes the robots they’re using at Penn Orthopaedic Surgery and the advantages for patients and the surgeon.
Kevin MA MD discusses endobronchial valve placement for emphysema/COPD. He shares this breakthrough treatment and how the specialists at Penn medicine help patients to breathe more easily without major surgery.
Taine Pechet, MD discusses the fundamentals of thoracic patient care. She shares how getting back to the basics is key to caring for these patients.
Namrata Patel MD discusses the implications of diagnostic delay and misdiagnosis in interstitial lung disease. She shares what Penn does differently to help get to a confirmed diagnosis for ILD, the recommendations for timing of referral, and the indications for lung transplant referral in the ILD population
Jenny Shao MD discusses complex hernia repair at Penn Medicine. She examines a report calling incisional hernia an epidemic in the US and she tells us about the tool developed by the Penn Hernia Program to predict the risk of incisional hernia. Finally, she shares what can be done to prevent incisional hernia and its recurrence.
Joshua Diamond MD MSCE discusses the waiting game when it comes to referral for lung transplantation. He shares how late referrals can impact outcomes, the benefits of earlier referral and the recommendations for timing of referral for better outcomes.
Dina Jacobs MD discusses Penn Medicine's multiple sclerosis team approach to treatment.
Gene Chang MD, PhD discusses mitral valve disease. He shares when it’s appropriate to refer, the clinical indications and the treatment options available at Penn Medicine.
Erica Pettke MD, MPH gives an update on the current guidelines for colorectal cancer screenings. She shares exciting advances in treatment and when it is important to refer to the specialists at Penn Medicine.
Rachel Brandstadter MD discusses MS and women's health at Penn Medicine. She shares what makes women particularly susceptible to the effects of MS and does MS symptom onset occurs in predictable patterns in women. She offers the latest treatments available specifically for women with MS and importantly other health areas women with MS need to pay extra attention to that they may be neglecting.
Penn Medicine’s ventricular assist device (VAD) implant specialists are among the most experienced in the nation. Listen as Joyce Wald DO, FACC discusses heart failure, VAD / TXP and why early referral is so important for these patients.
Christopher Perrone, MD discusses how and when to refer an MS patient to Penn Medicine. He shares what defines a multiple sclerosis expert and what combination of symptoms in a previously unaffected patient would suggest the need for referral.
He focuses on how a PCP can tell the difference between poor compliance and possibly a drug that's waning in efficacy and at what point it is appropriate for a PCP to request a second opinion on a diagnosis for something other than MS if he or she suspects MS is the issue.
In this panel discussion, Anjali Tiku Owens MD and Sharlene Day MD speak about the interdisciplinary team at the Center for Inherited Cardiac Disease Program at Penn Medicine. They examine the importance of family members being evaluated and how the program identifies those who may be affected. They offer the latest treatment options and research available for patients with inherited cardiac disease in their family-based approach to inherited cardiac care.
Caroline Cox, MD discusses gender confirmation surgery at Penn Medicine. She shares an overview of the LGBTQ Program and services offered at Penn Medicine
Daniel Yoshor, MD, is Penn Medicine’s New Chair of Neurosurgery. Join us as he discusses his research and the COVID-19 pandemic. In this podcast, he shares the development of a neurotechnology called the bionic eye and whether he thinks the discovery of other sequelae among Covid survivors would evolve over time and possibly have other implications for COVID patients including epilepsy or pituitary adenoma.
Developments in cancer treatment and care have dramatically improved survival for cancer patients, allowing them to live longer, fuller lives. However, just as these treatments can damage and kill cancer cells, they can also damage other parts of the body, including the heart.
Michael Fradley MD joins the show to discuss the Penn Medicine Cardio-Oncology Program that offers specialized cardiac care for cancer patients and survivors.
Adam Shiroff MD, FACS discusses Penn Medicine's Chest Wall Trauma and Slipping Rib Program. He examines diagnosis and treatment options available and when it is important to refer to Penn Medicine's Chest Wall Trauma and Slipping Rib Program.
Dimitriy Petrov, MD discusses a new program at Penn Medicine that’s offering remote second opinions to people who have received a brain or spine diagnosis. He tells us how the program works and what patients can benefit from this program.
Monika Sanghavi MD discusses spontaneous coronary artery dissection and heart attacks in women. She shares some of the factors that contribute to the pathogensis of SCAD, some studies that should lead clinicians to evaluate and treat it differently than the atherosclerotic blockages of arteries they were trained to look for, and the importance of thinking about SCAD as a diagnostic possibility before you enter the cath lab.
In this panel, Vincent Arlet, MD and Ali Ozturk MD discuss The Adult Spinal Deformity program at Penn Medicine. He shares how patients who once were told that nothing could be done for their severe spinal deformity can now can gain significant improvement in function and quality of life at the Penn Adult Spine Deformity Program.
In this podcast, Patrick Connolly MD shares how and when to refer to a spine specialist at Penn Medicine. He discusses diagnosis that require Neuro and Ortho specialists, how Penn specialists work with primary care physicians and the benefits of referring to the experts at the Penn Medicine Spine Center.
Monique Tanna, MD discusses CardioMEMS™ technology at Penn Medicine. She shares the benefits and cost effectiveness that has been shown with the CardioMEMS™ Heart Failure System and how it helps to monitor a patient and possibly ward off issues before they become problematic and end up with hospital readmission.
Roderick Spears, MD discusses Neurology Care in the Community. He shares how the experts at Penn Medicine are providing high quality care close to home. He talks about the benefits of having Penn Medicine in the community, and how the neurology department is able to provide service to a greater range of patients, not just geographically but across different subspecialties with more streamlined care for patients.
Penn Medicine's Gastrointestinal (GI) Cancer Program offers comprehensive care for the full spectrum of GI cancers. From diagnoses to complex cases to clinical trials and survivorship care, our team of experts works together to fight GI cancers.
Robert Roses, MD discusses Penn Medicine's Gastric Cancer and Surgery Program. He shares how our physicians are nationally and internationally recognized for their clinical expertise and research, and for their success in decreasing the incidence of local recurrence in most GI tumors and increasing the cure rate for tumors of the colon, rectum and pancreas.
Michael E. Hodde DO, FAAPMR and Arthur Kitt MD, MPH discuss the latest treatment options and procedures they perform at the Penn Medicine Spine Center and when it is important to refer to the specialists at Penn Medicine Spine Center.
William C. Welch MD FACS FICS discusses the benefits of a spine center model and how Penn's Spine Center functions to give the best outcomes to your patients.
In this panel discussion, Neil Malhotra MD and Amrit Khalsa MD examine the types of minimally invasive and traditional spine surgeries. They share the benefits and differences of each and when it is important to refer to the specialists at The Penn Medicine Spine Center.
In this panel discussion, Noel Williams MD and John Kucharczuk MD discuss Penn’s Esophageal Cancer and Surgery Program and when it is important to refer a patient to the specialists at Penn Medicine.
The HIPEC team at Penn Medicine is led by surgical oncologist Dr. Giorgos Karakousi. The HIPEC team includes specialists from medical oncology, anesthesiology, pathology, radiology, and critical care.
Giorgos Karakousis MD, FACS discusses why HIPEC is usually performed at academic medical centers like Penn Medicine and shares what makes it one of the most innovative treatments available today for complex cancers.
The Abramson Cancer Center recently awarded a Translational Center for Excellence grant to the Ovarian Cancer Research Center.
Ronny Drapkin, MD, PhD examines advances in Ovarian Cancer treatment research and what the objectives are for the Ovarian TCE.
Pancreatic Cancer will afflict over 55,000 people a year in the US. Often referred to as a silent disease because most people do not experience symptoms until its later stages, pancreatic cancer is annually the second most mortal cancer. The 5-year survival rate is just 8% for all patients with the diagnosis, but improves to around 25% if surgery can be performed.
Penn Surgery has one of the strongest, most expert, pancreatic surgical specialty units in the country. Penn Medicine’s group of five surgeons, directed by Dr. Vollmer, performs nearly 200 major operations – including Whipple resections - a year. They provide state-of-the-art surgical expertise which integrates with the other strengths of Penn Medicine including Medical and Radiation Oncology, and associations with basic and translational scientists in the medical school. They also offer the region’s only dedicated multidisciplinary program for pre-malignant pancreatic cysts.
Charles M. Vollmer, MD discusses The Pancreatic Cancer Surgery Center and The Whipple Procedure Program at Penn Medicine.
Andrew Kuntz, MD discusses the shoulder pain protocol and what makes shoulder and elbow orthopaedic care unique at Penn Orthopaedics.